Lumexa Imaging Holdings, Inc. (LMRI) bonds
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)
Close on Nov 18, 2026Market cap $1.35BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$837.07M
$15.55M due within a year
Net debt
$747.06M
After $90.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Lumexa Imaging's 10-Q for the period ended Dec 17, 2025
Lumexa Imaging's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| First Amendment | $450.00M |
| Refinancing Term Loan | $825.00M |
| Secured Revolving Line of Credit Facility | $250.00M |
| Secured Revolving Line of Credit Facility | $165.00M |
See a number that looks wrong?